149 related articles for article (PubMed ID: 15219793)
21. Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes.
Ganesan S; Ito MK
Metab Syndr Relat Disord; 2013 Aug; 11(4):251-5. PubMed ID: 23496027
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation.
Vivekananthan K; Mehra MR; Uber PA; DeGruiter H; Lavie CJ; Milani RV
J Assoc Physicians India; 2002 May; 50(5):682-4. PubMed ID: 12186124
[TBL] [Abstract][Full Text] [Related]
23. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury.
Melo AC; Valença SS; Gitirana LB; Santos JC; Ribeiro ML; Machado MN; Magalhães CB; Zin WA; Porto LC
Int Immunopharmacol; 2013 Sep; 17(1):57-64. PubMed ID: 23747588
[TBL] [Abstract][Full Text] [Related]
24. Statins promote the growth of experimentally induced cerebral aneurysms in estrogen-deficient rats.
Tada Y; Kitazato KT; Yagi K; Shimada K; Matsushita N; Kinouchi T; Kanematsu Y; Satomi J; Kageji T; Nagahiro S
Stroke; 2011 Aug; 42(8):2286-93. PubMed ID: 21737796
[TBL] [Abstract][Full Text] [Related]
25. Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men.
Nissinen MJ; Miettinen TE; Gylling H; Miettinen TA
Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):308-16. PubMed ID: 19695854
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)].
Golay A; Lehmann T; James R; Pometta D
Schweiz Med Wochenschr; 1993 Aug; 123(33):1553-8. PubMed ID: 8372340
[TBL] [Abstract][Full Text] [Related]
27. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain.
Björkhem I
J Intern Med; 2006 Dec; 260(6):493-508. PubMed ID: 17116000
[TBL] [Abstract][Full Text] [Related]
28. Can cheap generic statins achieve national cholesterol lowering targets?
Petty D; Lloyd D
J Health Serv Res Policy; 2008 Apr; 13(2):99-102. PubMed ID: 18416915
[TBL] [Abstract][Full Text] [Related]
29. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels.
Thelen KM; Laaksonen R; Päivä H; Lehtimäki T; Lütjohann D
J Clin Pharmacol; 2006 Jul; 46(7):812-6. PubMed ID: 16809807
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites.
Menter DG; Ramsauer VP; Harirforoosh S; Chakraborty K; Yang P; Hsi L; Newman RA; Krishnan K
PLoS One; 2011; 6(12):e28813. PubMed ID: 22216116
[TBL] [Abstract][Full Text] [Related]
31. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
[TBL] [Abstract][Full Text] [Related]
32. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
33. Pravastatin and simvastatin improves acetylsalicylic acid-mediated in vitro blood platelet inhibition.
Luzak B; Rywaniak J; Stanczyk L; Watala C
Eur J Clin Invest; 2012 Aug; 42(8):864-72. PubMed ID: 22409214
[TBL] [Abstract][Full Text] [Related]
34. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.
Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R
Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
[TBL] [Abstract][Full Text] [Related]
36. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
37. Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro.
Salman H; Bergman M; Djaldetti M; Bessler H
Biomed Pharmacother; 2008 Jan; 62(1):41-5. PubMed ID: 17768028
[TBL] [Abstract][Full Text] [Related]
38. Combined Treatment with Hydrophilic and Lipophilic Statins Improves Neurological Outcomes Following Experimental Cardiac Arrest in Mice.
Nakayama S; Taguchi N; Isaka Y; Nakamura T; Tanaka M
Neurocrit Care; 2020 Aug; 33(1):64-72. PubMed ID: 31591692
[TBL] [Abstract][Full Text] [Related]
39. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers.
Pierno S; De Luca A; Tricarico D; Roselli A; Natuzzi F; Ferrannini E; Laico M; Camerino DC
J Pharmacol Exp Ther; 1995 Dec; 275(3):1490-6. PubMed ID: 8531120
[TBL] [Abstract][Full Text] [Related]
40. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins.
Miettinen TA; Gylling H; Lindbohm N; Miettinen TE; Rajaratnam RA; Relas H;
J Lab Clin Med; 2003 Feb; 141(2):131-7. PubMed ID: 12577049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
